RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jerzy Leszczynski to Fullerenes

This is a "connection" page, showing publications Jerzy Leszczynski has written about Fullerenes.
Connection Strength

4.131
  1. Ahmed L, Rasulev B, Kar S, Krupa P, Mozolewska MA, Leszczynski J. Inhibitors or toxins? Large library target-specific screening of fullerene-based nanoparticles for drug design purpose. Nanoscale. 2017 Jul 27; 9(29):10263-10276.
    View in: PubMed
    Score: 0.586
  2. Toropova AP, Toropov AA, Veselinovic AM, Veselinovic JB, Benfenati E, Leszczynska D, Leszczynski J. Nano-QSAR: Model of mutagenicity of fullerene as a mathematical function of different conditions. Ecotoxicol Environ Saf. 2016 Feb; 124:32-36.
    View in: PubMed
    Score: 0.517
  3. Reis H, Rasulev B, Papadopoulos MG, Leszczynski J. Reliable but Timesaving: In Search of an Efficient Quantum-chemical Method for the Description of Functional Fullerenes. Curr Top Med Chem. 2015; 15(18):1845-58.
    View in: PubMed
    Score: 0.490
  4. Turabekova M, Rasulev B, Theodore M, Jackman J, Leszczynska D, Leszczynski J. Immunotoxicity of nanoparticles: a computational study suggests that CNTs and C60 fullerenes might be recognized as pathogens by Toll-like receptors. Nanoscale. 2014 Apr 07; 6(7):3488-95.
    View in: PubMed
    Score: 0.466
  5. Ahmed L, Rasulev B, Turabekova M, Leszczynska D, Leszczynski J. Receptor- and ligand-based study of fullerene analogues: comprehensive computational approach including quantum-chemical, QSAR and molecular docking simulations. Org Biomol Chem. 2013 Sep 21; 11(35):5798-808.
    View in: PubMed
    Score: 0.449
  6. Toropova AP, Toropov AA, Benfenati E, Gini G, Leszczynska D, Leszczynski J. CORAL: QSPR models for solubility of [C60] and [C70] fullerene derivatives. Mol Divers. 2011 Feb; 15(1):249-56.
    View in: PubMed
    Score: 0.352
  7. Toropov AA, Toropova AP, Benfenati E, Leszczynska D, Leszczynski J. SMILES-based optimal descriptors: QSAR analysis of fullerene-based HIV-1 PR inhibitors by means of balance of correlations. J Comput Chem. 2010 Jan 30; 31(2):381-92.
    View in: PubMed
    Score: 0.349
  8. Toropov AA, Toropova AP, Benfenati E, Leszczynska D, Leszczynski J. InChI-based optimal descriptors: QSAR analysis of fullerene[C60]-based HIV-1 PR inhibitors by correlation balance. Eur J Med Chem. 2010 Apr; 45(4):1387-94.
    View in: PubMed
    Score: 0.347
  9. Shukla MK, Dubey M, Leszczynski J. Theoretical investigation of electronic structures and properties of C60-gold nanocontacts. ACS Nano. 2008 Feb; 2(2):227-34.
    View in: PubMed
    Score: 0.304
  10. Yanov I, Leszczynski J. The molecular structure and electronic spectrum of the C@C60 endohedral complex: an ab initio study. J Mol Graph Model. 2001; 19(2):232-5.
    View in: PubMed
    Score: 0.186
  11. Cook SM, Aker WG, Rasulev BF, Hwang HM, Leszczynski J, Jenkins JJ, Shockley V. Choosing safe dispersing media for C60 fullerenes by using cytotoxicity tests on the bacterium Escherichia coli. J Hazard Mater. 2010 Apr 15; 176(1-3):367-73.
    View in: PubMed
    Score: 0.086
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support